"Immune System Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
| Descriptor ID |
D007154
|
| MeSH Number(s) |
C20
|
| Concept/Terms |
Immune System Diseases- Immune System Diseases
- Disease, Immune System
- Diseases, Immune System
- Immune System Disease
- Immunological Diseases
- Disease, Immunological
- Diseases, Immunological
- Immunological Disease
- Immune Disorders
- Disorder, Immune
- Disorders, Immune
- Immune Disorder
- Immunologic Diseases
- Disease, Immunologic
- Diseases, Immunologic
- Immunologic Disease
- Diseases of Immune System
- Immune Diseases
- Disease, Immune
- Diseases, Immune
- Immune Disease
|
Below are MeSH descriptors whose meaning is more general than "Immune System Diseases".
Below are MeSH descriptors whose meaning is more specific than "Immune System Diseases".
This graph shows the total number of publications written about "Immune System Diseases" by people in this website by year, and whether "Immune System Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immune System Diseases" by people in Profiles.
-
Pecaut MJ, Mao XW, Bellinger DL, Jonscher KR, Stodieck LS, Ferguson VL, Bateman TA, Mohney RP, Gridley DS. Is spaceflight-induced immune dysfunction linked to systemic changes in metabolism? PLoS One. 2017; 12(5):e0174174.
-
Charbonnier LM, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, Massaad MJ, Garcia-Lloret M, Hanna-Wakim R, Dbaibo G, Alangari AA, Alsultan A, Al-Zahrani D, Geha RS, Chatila TA. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol. 2015 Jan; 135(1):217-27.
-
Mathias SD, Gao SK, Miller KL, Cella D, Snyder C, Turner R, Wu A, Bussel JB, George JN, McMillan R, Wysocki DK, Nichol JL. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008 Feb 08; 6:13.
-
George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
-
Magro CM, Crowson AN. Eosinophilic pustular follicular reaction: a paradigm of immune dysregulation. Int J Dermatol. 1994 Mar; 33(3):172-8.